Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Citi
Dow
Daiichi Sankyo
Chubb
Colorcon
Queensland Health
Boehringer Ingelheim
US Army

Generated: September 21, 2018

DrugPatentWatch Database Preview

Actavis Elizabeth Company Profile

« Back to Dashboard

What is the competitive landscape for ACTAVIS ELIZABETH, and what generic and branded alternatives to ACTAVIS ELIZABETH drugs are available?

ACTAVIS ELIZABETH has one hundred and twenty-three approved drugs.

There are eight tentative approvals on ACTAVIS ELIZABETH drugs.

Drugs and US Patents for Actavis Elizabeth

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth OXYMORPHONE HYDROCHLORIDE oxymorphone hydrochloride TABLET, EXTENDED RELEASE;ORAL 079046-007 Jul 11, 2013 AB RX No No ➤ Sign Up ➤ Sign Up
Actavis Elizabeth ISOSORBIDE MONONITRATE isosorbide mononitrate TABLET, EXTENDED RELEASE;ORAL 075306-001 Dec 31, 1998 DISCN No No ➤ Sign Up ➤ Sign Up
Actavis Elizabeth MIRTAZAPINE mirtazapine TABLET, ORALLY DISINTEGRATING;ORAL 076689-001 Aug 31, 2005 DISCN No No ➤ Sign Up ➤ Sign Up
Actavis Elizabeth OXYMORPHONE HYDROCHLORIDE oxymorphone hydrochloride TABLET, EXTENDED RELEASE;ORAL 079046-003 Jul 11, 2013 AB RX No No ➤ Sign Up ➤ Sign Up
Actavis Elizabeth OXYCODONE AND ACETAMINOPHEN acetaminophen; oxycodone hydrochloride TABLET;ORAL 040800-002 Apr 3, 2012 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Dow
Farmers Insurance
Cantor Fitzgerald
Fuji
Chinese Patent Office
Boehringer Ingelheim
QuintilesIMS
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.